tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

IPSC Stock Latest News

Century Therapeutics Announces Major Workforce Reduction
Company AnnouncementsCentury Therapeutics Announces Major Workforce Reduction
9h ago
8K
IPSC
Century Therapeutics Holds 2025 Annual Stockholders Meeting
PremiumCompany Announcements
Century Therapeutics Holds 2025 Annual Stockholders Meeting
21d ago
8K
IPSC
Century Therapeutics Reports Strong Q1 2025 Earnings
PremiumCompany Announcements
Century Therapeutics Reports Strong Q1 2025 Earnings
2M ago
IPSC
Century Therapeutics Reports Strong Q1 2025 Financial Results
PremiumCompany Announcements
Century Therapeutics Reports Strong Q1 2025 Financial Results
2M ago
8K
IPSC
Century Therapeutics: Strategic Advancements and Promising Preclinical Data Justify Buy Rating
PremiumRatings
Century Therapeutics: Strategic Advancements and Promising Preclinical Data Justify Buy Rating
2M ago
IPSC
Century Therapeutics price target lowered to $2 from $5 at H.C. Wainwright
PremiumThe FlyCentury Therapeutics price target lowered to $2 from $5 at H.C. Wainwright
3M ago
IPSC
Century Therapeutics price target lowered to $7 from $11 at Chardan
Premium
The Fly
Century Therapeutics price target lowered to $7 from $11 at Chardan
4M ago
IPSC
Century Therapeutics price target lowered to $5 from $12 at Guggenheim
Premium
The Fly
Century Therapeutics price target lowered to $5 from $12 at Guggenheim
4M ago
IPSC
Century Therapeutics Reports 2024 Financial Results and Strategic Updates
PremiumCompany Announcements
Century Therapeutics Reports 2024 Financial Results and Strategic Updates
4M ago
IPSC
Century Therapeutics price target lowered to $2 from $4 at Piper Sandler
PremiumThe Fly
Century Therapeutics price target lowered to $2 from $4 at Piper Sandler
4M ago
IPSC
Century Therapeutics Re-prioritizes Pipeline for Key Programs
PremiumCompany Announcements
Century Therapeutics Re-prioritizes Pipeline for Key Programs
4M ago
8K
IPSC
Century Therapeutics trading resumes
PremiumThe Fly
Century Therapeutics trading resumes
4M ago
IPSC
Century Therapeutics trading halted, news pending
PremiumThe FlyCentury Therapeutics trading halted, news pending
4M ago
IPSC
Century announces investigator-initiated Phase 1/2 trial of CNTY-101
Premium
The Fly
Century announces investigator-initiated Phase 1/2 trial of CNTY-101
6M ago
IPSC
Century Therapeutics Unveils Advances in Cell Therapies
Premium
Company Announcements
Century Therapeutics Unveils Advances in Cell Therapies
6M ago
8K
IPSC
Century Therapeutics price target lowered to $4 from $12 at Piper Sandler
PremiumThe Fly
Century Therapeutics price target lowered to $4 from $12 at Piper Sandler
6M ago
BMY
IPSC
Century Therapeutics Faces Termination of BMS Agreement
PremiumCompany Announcements
Century Therapeutics Faces Termination of BMS Agreement
7M ago
8K
IPSC
Century Therapeutics, Inc. Demonstrates Strong Financial Management with No Senior Securities Defaults
PremiumCompany Announcements
Century Therapeutics, Inc. Demonstrates Strong Financial Management with No Senior Securities Defaults
8M ago
IPSC
Century Therapeutics price target lowered to $11 from $17 at Chardan
PremiumThe Fly
Century Therapeutics price target lowered to $11 from $17 at Chardan
8M ago
IPSC
Century Therapeutics price target lowered to $5 from $9 at H.C. Wainwright
PremiumThe FlyCentury Therapeutics price target lowered to $5 from $9 at H.C. Wainwright
8M ago
IPSC
Century Therapeutics Reports Q3 Results & Strategic Updates
Premium
Company Announcements
Century Therapeutics Reports Q3 Results & Strategic Updates
8M ago
IPSC
Century Therapeutics reports Q3 EPS (37c), consensus (45c)
Premium
The Fly
Century Therapeutics reports Q3 EPS (37c), consensus (45c)
8M ago
IPSC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >